メチシリン感受性, 中等度耐性および高度耐性黄色ブドウ球菌に対する16抗菌剤の耐性頻度の比較

臨床より分離された黄色ブドウ球菌351株に対する16抗菌剤の感受性を検討した。それらの株をmethicillinの感受性分布により, 感受性株 (MSSA), 中等度耐性株 (L-MRSA) および高度耐性株 (H-MRSA) の3群に分類したところ, β-lactams, fluoroquinolonesおよびerythromycinのH-MRSAに対する耐性株の分離頻度は, L-MRSA群のそれより有意に高いことが示されたが, その他の薬剤では有意な差は認められなかった。...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 39; no. 12; pp. 1148 - 1151
Main Authors 村谷, 哲郎, 渡邊, 正人, 三橋, 進, 吉田, 益史
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本化学療法学会 1991
Online AccessGet full text
ISSN0009-3165
1884-5894
DOI10.11250/chemotherapy1953.39.1148

Cover

Abstract 臨床より分離された黄色ブドウ球菌351株に対する16抗菌剤の感受性を検討した。それらの株をmethicillinの感受性分布により, 感受性株 (MSSA), 中等度耐性株 (L-MRSA) および高度耐性株 (H-MRSA) の3群に分類したところ, β-lactams, fluoroquinolonesおよびerythromycinのH-MRSAに対する耐性株の分離頻度は, L-MRSA群のそれより有意に高いことが示されたが, その他の薬剤では有意な差は認められなかった。
AbstractList 臨床より分離された黄色ブドウ球菌351株に対する16抗菌剤の感受性を検討した。それらの株をmethicillinの感受性分布により, 感受性株 (MSSA), 中等度耐性株 (L-MRSA) および高度耐性株 (H-MRSA) の3群に分類したところ, β-lactams, fluoroquinolonesおよびerythromycinのH-MRSAに対する耐性株の分離頻度は, L-MRSA群のそれより有意に高いことが示されたが, その他の薬剤では有意な差は認められなかった。
Author 渡邊, 正人
吉田, 益史
三橋, 進
村谷, 哲郎
Author_xml – sequence: 1
  fullname: 村谷, 哲郎
  organization: エピゾーム研究所
– sequence: 1
  fullname: 渡邊, 正人
  organization: エピゾーム研究所
– sequence: 1
  fullname: 三橋, 進
  organization: エピゾーム研究所
– sequence: 1
  fullname: 吉田, 益史
  organization: エピゾーム研究所
BookMark eNpdkEtLw0AUhQepYK39D7o3dSaTSWaWUnxBoRtdh2kysS19SNpNdyZxYavQLsTqSgWpYKkFu1Cs-GfGvv6FEYuIm3M53733LM4yiJTKJQHAGoIJhFQCN6ysKJarWeHyoxpiBCcwCzcaXQBRRKmmEMq0CIhCCJmCkU6WQLxSyWUgRAjqKlWjwJfBnQw86b_I4FEGg_HJzajZHh8_rK9-vvYmvfrorTM9boVAeg3pn0pvMOte_cLZ8GRaf5bBpQzq0u9MWsG0eS697qj_Ib1r6Z8hfdxoh2xUv5fe0_zpdhgGhHbcv5i-Bytg0eGFiojPZwwcbG_tJ3eVVHpnL7mZUvIqZlDROBSOpTKb6LZtCOYIzBzLsKiFCLWFxmyMONcoVg1H2Niwqa4Sx-AioxONIAfHQPonN1-p8kNhHrm5IndrJnerOasgzP9lmpiZSJ3rd6t_Lrlr5jn-Ahuwoyk
ContentType Journal Article
Copyright 社団法人日本化学療法学会
Copyright_xml – notice: 社団法人日本化学療法学会
DOI 10.11250/chemotherapy1953.39.1148
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1884-5894
EndPage 1151
ExternalDocumentID article_chemotherapy1953_39_12_39_12_1148_article_char_ja
GroupedDBID 53G
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
JSF
JSH
KQ8
RJT
RZJ
ZOHVM
ID FETCH-LOGICAL-j2390-4a0efc29d56dd7e9fe39fc7c8c158de49d31aa48327fed37d8625f7aeb65451f3
ISSN 0009-3165
IngestDate Wed Sep 03 06:20:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 12
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2390-4a0efc29d56dd7e9fe39fc7c8c158de49d31aa48327fed37d8625f7aeb65451f3
OpenAccessLink https://www.jstage.jst.go.jp/article/chemotherapy1953/39/12/39_12_1148/_article/-char/ja
PageCount 4
ParticipantIDs jstage_primary_article_chemotherapy1953_39_12_39_12_1148_article_char_ja
PublicationCentury 1900
PublicationDate 19910000
PublicationDateYYYYMMDD 1991-01-01
PublicationDate_xml – year: 1991
  text: 19910000
PublicationDecade 1990
PublicationTitle CHEMOTHERAPY
PublicationTitleAlternate CHEMOTHERAPY
PublicationYear 1991
Publisher 公益社団法人 日本化学療法学会
Publisher_xml – name: 公益社団法人 日本化学療法学会
References 12) Qoronfleh M W, Wilkinson B J: Effects of growth of methicillin-resistant and-susceptible Staphylococcus aureus in the presence of β-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Antimicrob Agent Chemother 29: 250-257, 1986
6) Kojima K, Inoue M, Mitsuhashi S: In vitro activity of AT-4140 against quinolone-and methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemother 34: 1123-1127, 1990
5) Daum T E, Schaberg D R, Terpenning M S, Sottile W S, Kauffman C A: Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 34: 1862-1863, 1990
3) Lyon B R, Skurray R: Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiological Reviews 51: 88-134, 1987
7) Murakami K, Nomura K, Doi M, Yoshida T: Production of low-affinity penicillin-binding protein by low-and high-resistance groups of methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemother 31: 1307-1311, 1987
10) Inoue M, Okubo T, Okamoto R, Hashimoto H: 64 th Japanese Society for Bacteriology: Abstract No.D-II-13, 1991
9) Utsui Y, Yokota T: Role of an altered penicillin-binding protein in methicillin-and cephem-resistant Staphylococcus aureus. Antimicrob Agent Chemother 28: 397-403, 1985
13) Yoshida S, Kojima T, Inoue M, Mitsuhashi S: Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. Antimicrob Agent Chemother 35: 368-370, 1991
16) Novick P R, Murphy E: MLS-resistance determinants in Staphylococcus aureus and their molecular evolution. J Antimicrob Chemother16: suppl. A, 101-110, 1985
15) Yoshida S, Wakebe H, Nakanishi N, Kojima T, Inoue M, Mitsuhashi S: 39th Japanese Society for Chemotherapy, Abstract No.187, 1991
2) Goto H, Goto M, Oka S, Shimada K, Shimizu K, Goto S, Ueno K, Hara K: The prevalence of multiply resistant Staphylococcus aureus in Japan during 1986 and 1988. Chemotherapy 37: 1334-1341, 1989
11) Bruns W, Keppeler H, Baucks R: Suppression of intrinsic resistance to penicillins in Staphylococcus aureus by polidocanol, a dodecyl polyethyleneoxid ether. Antimicrob Agent Chemother 27: 632-639, 1985
1) Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukushima Y, Fukayama S. Ishihara R, Oda S. Tanaka S, Sato K: Yearly changes in resistance to new quinolones and multiple drug-regimens in clinical isolates. Chemotherapy 38: 1012-1019, 1990
8) Ubukata K, Yamashita N, Konno M: Occurrence of a β-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agent Chemother 27: 851-857, 1985
14) Okuda J, Okamoto S, Takahata M, Nishino T: 39th Japanese Society for Chemotherapy, Abstract No.186, 1991
4) Mitsuhashi N, Mizuno M: Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) strains and treatment of in-patients infected with MRSA. Chemotherapy 38: 927-932, 1990
References_xml – reference: 11) Bruns W, Keppeler H, Baucks R: Suppression of intrinsic resistance to penicillins in Staphylococcus aureus by polidocanol, a dodecyl polyethyleneoxid ether. Antimicrob Agent Chemother 27: 632-639, 1985
– reference: 12) Qoronfleh M W, Wilkinson B J: Effects of growth of methicillin-resistant and-susceptible Staphylococcus aureus in the presence of β-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Antimicrob Agent Chemother 29: 250-257, 1986
– reference: 9) Utsui Y, Yokota T: Role of an altered penicillin-binding protein in methicillin-and cephem-resistant Staphylococcus aureus. Antimicrob Agent Chemother 28: 397-403, 1985
– reference: 7) Murakami K, Nomura K, Doi M, Yoshida T: Production of low-affinity penicillin-binding protein by low-and high-resistance groups of methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemother 31: 1307-1311, 1987
– reference: 16) Novick P R, Murphy E: MLS-resistance determinants in Staphylococcus aureus and their molecular evolution. J Antimicrob Chemother16: suppl. A, 101-110, 1985
– reference: 6) Kojima K, Inoue M, Mitsuhashi S: In vitro activity of AT-4140 against quinolone-and methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemother 34: 1123-1127, 1990
– reference: 14) Okuda J, Okamoto S, Takahata M, Nishino T: 39th Japanese Society for Chemotherapy, Abstract No.186, 1991
– reference: 2) Goto H, Goto M, Oka S, Shimada K, Shimizu K, Goto S, Ueno K, Hara K: The prevalence of multiply resistant Staphylococcus aureus in Japan during 1986 and 1988. Chemotherapy 37: 1334-1341, 1989
– reference: 8) Ubukata K, Yamashita N, Konno M: Occurrence of a β-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agent Chemother 27: 851-857, 1985
– reference: 15) Yoshida S, Wakebe H, Nakanishi N, Kojima T, Inoue M, Mitsuhashi S: 39th Japanese Society for Chemotherapy, Abstract No.187, 1991
– reference: 1) Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukushima Y, Fukayama S. Ishihara R, Oda S. Tanaka S, Sato K: Yearly changes in resistance to new quinolones and multiple drug-regimens in clinical isolates. Chemotherapy 38: 1012-1019, 1990
– reference: 10) Inoue M, Okubo T, Okamoto R, Hashimoto H: 64 th Japanese Society for Bacteriology: Abstract No.D-II-13, 1991
– reference: 13) Yoshida S, Kojima T, Inoue M, Mitsuhashi S: Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. Antimicrob Agent Chemother 35: 368-370, 1991
– reference: 5) Daum T E, Schaberg D R, Terpenning M S, Sottile W S, Kauffman C A: Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 34: 1862-1863, 1990
– reference: 3) Lyon B R, Skurray R: Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiological Reviews 51: 88-134, 1987
– reference: 4) Mitsuhashi N, Mizuno M: Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) strains and treatment of in-patients infected with MRSA. Chemotherapy 38: 927-932, 1990
SSID ssib001106282
ssj0000626693
ssib058492509
ssib005879733
ssib008506721
Score 1.2609926
Snippet 臨床より分離された黄色ブドウ球菌351株に対する16抗菌剤の感受性を検討した。それらの株をmethicillinの感受性分布により, 感受性株 (MSSA), 中等度耐性株 (L-MRSA) および高度耐性株 (H-MRSA) の3群に分類したところ, β-lactams,...
SourceID jstage
SourceType Publisher
StartPage 1148
Title メチシリン感受性, 中等度耐性および高度耐性黄色ブドウ球菌に対する16抗菌剤の耐性頻度の比較
URI https://www.jstage.jst.go.jp/article/chemotherapy1953/39/12/39_12_1148/_article/-char/ja
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX CHEMOTHERAPY, 1991/12/25, Vol.39(12), pp.1148-1151
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1NaxQxdCgVxIsoKn5TwdzcuvOZ5JjZzrIoftJCb8vMzsxhwSqlPeipu9ODW4X2UKyeVJAKllqwB8WKf2bc7fZf-F4mOzuVKlqEJWRe3kveR2aSl01eNO2q7QQwkYh9mLnFYcnyzXKJ08AumZYVhdS3AhrKaJ-3ndqUdWPanh4ZXS3sWpqfC8YbTw48V3IYqwIM7IqnZP_BsnmlAIA82BdSsDCkf2Vj4pmEmUToKsOyjEFcOigSKuOaxHMIswivEs8mrEo4lZAyERT1TDyLuIyICeJRTBlHPFcQ4RCPZRsihgSebIwJ1R5jCoLNcCJcwtkfyTlxXeQGiyBvKC65M5CEq5qRnCItABG5SlhFtQWtQBOiSlxPQfiAirm6I1sTUsyczsaKhTWowDuYNVFG7obs58gOtsYl126FZFfj5GEeat6tO5M17764m3sHSMEnCNclRRnNIjVtE25KobmU1Sviow10WWIg-xLfQYMIU5pIkOHSirIZKgtQgMTN8DnK4hpDNFtqkEtVWsiJRIMHV9pQ9geFH6ojkcO1H1kOiq4UKChqEfVuI0TIzgW253bOo2QblC9smalIehutgEa2pUSZbaWoQ_q8yEIlc7FvXOUwmme3foxH2VDKmFWyWXaF9WCszQJXDb4pRmHkRL-8MAsDR0U_eISHOTu8l_BFe6COKD7Gf4LH4eswrGJfAHX1etZ_JambvK4bKkXa-hDTn603wes6YlCq40bhm_cK_y3reO64EOSOUU4LThPGgCwEHYQZPgeeeb7yC9SOw_MrHlFtR7UrA9mu_04ymCI3wWEcbDaV89_JE9px5biOiYz5k9pI0z-ltdPkbZq00vbnNPmQJtu9xdfd5bXewvtrYz--bO5udrpf1_sLKwBIW0tp-2na2t7beJkD93YW-51PafIiTTppe313JekvP09bG92t72nrVdp-pju9pTWAdTvv0tZHRfRmByqAx97Wav9bclqbqnqTlVpJ3epSahomL8N4UI7ihsFD2wlDGvE4MnncoA3W0G0WRhYPTd33LZhp0DgKTRoyx7Bj6keBA96eHptntNGZhzPRWW2MWnEYm34QGmVuBbh2FIUWdRilPvcbcXhOq2Uqqz_KQvfUD90Xzv-_qi5ox7L9pvi7qI3Ozc5Hl8CzmQsuy472E1yCHmY
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E3%83%A1%E3%83%81%E3%82%B7%E3%83%AA%E3%83%B3%E6%84%9F%E5%8F%97%E6%80%A7%2C+%E4%B8%AD%E7%AD%89%E5%BA%A6%E8%80%90%E6%80%A7%E3%81%8A%E3%82%88%E3%81%B3%E9%AB%98%E5%BA%A6%E8%80%90%E6%80%A7%E9%BB%84%E8%89%B2%E3%83%96%E3%83%89%E3%82%A6%E7%90%83%E8%8F%8C%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B16%E6%8A%97%E8%8F%8C%E5%89%A4%E3%81%AE%E8%80%90%E6%80%A7%E9%A0%BB%E5%BA%A6%E3%81%AE%E6%AF%94%E8%BC%83&rft.jtitle=CHEMOTHERAPY&rft.au=%E6%9D%91%E8%B0%B7%2C+%E5%93%B2%E9%83%8E&rft.au=%E6%B8%A1%E9%82%8A%2C+%E6%AD%A3%E4%BA%BA&rft.au=%E4%B8%89%E6%A9%8B%2C+%E9%80%B2&rft.au=%E5%90%89%E7%94%B0%2C+%E7%9B%8A%E5%8F%B2&rft.date=1991&rft.pub=%E5%85%AC%E7%9B%8A%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8C%96%E5%AD%A6%E7%99%82%E6%B3%95%E5%AD%A6%E4%BC%9A&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=39&rft.issue=12&rft.spage=1148&rft.epage=1151&rft_id=info:doi/10.11250%2Fchemotherapy1953.39.1148&rft.externalDocID=article_chemotherapy1953_39_12_39_12_1148_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon